Liminal BioSciences Inc trades with the ticker LMNL on the TSX and is in the Biotechnology industry.
Overview
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on discovery, development, and commercialization of novel treatments for patients suffering from diseases that have unmet medical needs. It operates through two segments, Small Molecule Therapeutics and Plasma Derived Therapeutics. The Small Molecule Therapeutics segment’s lead product candidate is fezagepras (PBI-4050) for the treatment of idiopathic pulmonary fibrosis, respiratory diseases, and Alström Syndrome. The Plasma Derived Therapeutics segment provides Plasma Protein Purification System, a multi-product sequential purification process for the extraction and purification of therapeutic proteins from human plasma. It also engages in developing Ryplazim for the treatment of congenital plasminogen deficiency. The company operates in Canada, the United Kingdom, and the United States. The company was formerly known as Prometic Life Sciences Inc. and changed its name to Liminal BioSciences Inc. in October 2019. Liminal BioSciences Inc. was incorporated in 1994 and is headquartered in Laval, Canada.
Looking to invest in Liminal BioSciences Inc? Our analysis brings in the key facts, competitor research and valuation metrics for you to make an informed decision.
Table of Contents
show
LMNL.TO Stock Price and Key Stats
ETF Key Stats
Exchange: TSX
Market Cap : $539.542MM
PE Ratio: 1.276
Price: #N/A (Updated: 3/12/2024 0:47:16)
Liminal BioSciences Inc (LMNL) vs Competitors in Biotechnology
Lets see how LMNL.TO stacks up against others in the Biotechnology asset management industry. We have identified its main peers as:Aeterna Zentaris Inc, Aptose Biosciences Inc, BELLUS Health Inc, Fennec Pharmaceuticals Inc, IMV Inc
.Biotechnology Industry Comparisons
| Company | Market Cap ($MM) | P/E Ratio | EV/EBITDA | Dividend Yield |
|---|---|---|---|---|
| Aeterna Zentaris Inc (AEZS) | $12.674 | N/A | 1.709 | N/A% |
| Aptose Biosciences Inc (APS) | $33.927 | N/A | -0.231 | N/A% |
| BELLUS Health Inc (BLU) | $2,470.298 | N/A | -16.428 | 0.0% |
| Fennec Pharmaceuticals Inc (FRX) | $352.565 | N/A | -21.793 | N/A% |
| IMV Inc (IMV) | $13.117 | N/A | -0.843 | 0.0% |
EV/EBITDA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization – this ratio compares the value of a company, including debt, to the company’s cash earnings less non-cash expenses
Industry: companies that have a lot in common
Market Cap: Market Capitalization – the total value of all a corporation’s stock
N/A: Not Applicable or Not Available
P/E: Price-to-Earnings – this ratio relates a corporation’s share price to its earnings per share
Price: Stock Price – current value to buyers and sellers
Dividend Yield: Dividend or Distribution Yield
Comparisons within Biotechnology
- Liminal BioSciences Inc (LMNL) vs Aeterna Zentaris Inc (AEZS)
- LMNL has higher EPS (19.281 vs -6.47). AEZS has a P/E under 0, indicating LMNL (P/E 1.276) is in a better position.
- Liminal BioSciences Inc (LMNL) vs Aptose Biosciences Inc (APS)
- LMNL has higher EPS (19.281 vs -10.45). APS has a P/E under 0, indicating LMNL (P/E 1.276) is in a better position.
- Liminal BioSciences Inc (LMNL) vs BELLUS Health Inc (BLU)
- LMNL has higher EPS (19.281 vs -0.96). BLU provides dividends, while LMNL does not. BLU has a P/E under 0, indicating LMNL (P/E 1.276) is in a better position.
- Liminal BioSciences Inc (LMNL) vs Fennec Pharmaceuticals Inc (FRX)
- LMNL has higher EPS (19.281 vs -1.01). FRX has a P/E under 0, indicating LMNL (P/E 1.276) is in a better position.
- Liminal BioSciences Inc (LMNL) vs IMV Inc (IMV)
- LMNL has higher EPS (19.281 vs -6.11). IMV provides dividends, while LMNL does not. IMV has a P/E under 0, indicating LMNL (P/E 1.276) is in a better position.
Our Recommendation: Review
May not stand out on key metrics or lacks sufficient data for a strong recommendation.
How to Buy LMNL stock on the TSX
You can buy on pretty much any online brokerage in Canada, since it trades on the TSX. If you are looking for some easy options take a look at these two:| Image | Product Title | Features | Price |
|---|---|---|---|
Editor's Choice  |
| Get $25 Signup Bonus | |
Reliable Pick  |
| Get $50 Free Stock Trades |
